• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
SUBSCRIBE
2 Minute Medicine
Subscribe
EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine
Home All Specialties Pediatrics

Targeting Children’s Asthma Care measures reduced asthma readmission rates

byEmilia HermannandCordelia Ross
June 22, 2014
in Pediatrics, Pulmonology
Reading Time: 3 mins read
Palliative chemotherapy associated with more ICU treatment at end-of-life
Share on FacebookShare on Twitter

1. Quality improvement (QI) initiatives targeting Children’s Asthma Care (CAC) measures reduced hospital readmission rates for asthma by 71% at 91 to 180 days post-discharge.

2. Post-discharge follow-up at a patient-centered medical home also increased significantly, from 69% to 90% attendance, following implementation of QI initiatives.

Evidence Rating Level: 2 (Good)

Study Rundown: Asthma is the most common chronic childhood disorder and asthma-related hospitalizations are a significant burden on the health care system. This study evaluated a quality improvement (QI) initiative at the Kapi’olani Medical Center for Women and Children in Hawaii that targeted Children’s Asthma Care (CAC) process measures. Inpatient CAC measures focus on clinical management (e.g. bronchodilator and corticosteroid use), while the outpatient component (CAC-3) focuses on follow-up at a patient-centered medical home (PCMH). CAC measures were targeted by implementation of inpatient automated order sets as well as pre-discharge scheduling of a PCMH follow-up appointment. Overall achievement of inpatient CAC measures was >99% throughout the study period and the CAC-3 compliance rate improved significantly during the study period (P < 0.001). ED utilization for asthma exacerbation did not vary, but hospital readmission rates were lower during the follow-up period. Overall, these results suggest that targeting CAC measures may reduce asthma hospital readmission rates and increase follow-up appointment attendance. This study is limited by a lack of control group, and these results represent only one hospital’s experience and may not be generalizable.

Click to read the study, published in Pediatrics

Relevant Reading: Follow-up after acute asthma episodes: what improves future outcomes?

RELATED REPORTS

Artificial intelligence decision support software improved spirometry diagnosis performance in primary care

Dupilumab use is associated with lower all-cause mortality but increased risk of lymphoma in asthma patients

Dupilumab treatment is associated with improved mortality but increased risk of lymphoma in asthma patients

Study Author, Dr. Lora Bergert, MD, talks to 2 Minute Medicine: Pediatric Hospitalist Division Head, Kapiolani Medical Center for Women and Children; Assistant Professor of Pediatrics, University of Hawaii. 

“In the United States, pediatric asthma continues to be a leading cause of hospital admissions, with readmission rates between 10 percent and 40 percent.  Our study looked at the development of a multidisciplinary Asthma Task Force focusing on the Children’s Asthma Care Measures (CAC) and incorporated tracking compliance with follow-up appointments with the patient-centered medical home.  The study took place from January 2008 through June 2012 in children admitted with asthma. We achieved close to 100% compliance with all 3 CAC measures and showed improvement in compliance with their follow up appointments from 69% to 90%.  We concluded that compliance with the asthma core measures and attendance at the post-discharge follow-up visit was associated with reduced hospital admission rates at 91 to 180 days post-discharge. These findings support the concept that continuity of care with the patient-centered medical home at hospital discharge is beneficial for children with asthma.”

In-Depth [outcomes study]: This study evaluated the success of a QI initiative at the Kapi’olani Medical Center for Women and Children in Hawaii targeting CAC outcome measures. Compliance to CAC measures was evaluated for all patients aged 2 to 18 admitted with asthma between January 1, 2008 and June 30, 2012, following implementation of the initiative. 231 children were discharged with asthma prior to the QI intervention and 532 patients were identified following the intervention. CAC outcomes measures for inpatient asthma care remained at >99% compliance throughout the study period, with no significant change following the intervention. Outpatient CAC measures, however, improved significantly during the study period, from an initial mean compliance of 74% to 95% (P < 0.001), with significantly improved follow-up rates at a PCMH from 69% attendance at the start of the study to 90% (P < 0.001). ED utilization for asthma exacerbation did not change following the intervention, however, re-admission rates were 71% lower in the 91 to 180-day range following discharge (OR: 0.29; 95% CI: 0.11–0.78).

More from this author: Seasonal increase in primary care visits for asthma, PCR associated with limited diagnostic utility in viral URI, Lower household income associated with higher pediatric inpatient costs, EHR useful for pediatric health insurance surveillance, Commercially purchased breast milk contaminated with pathogenic bacteria

Image: PD

©2012-2014 2minutemedicine.com. All rights reserved. No works may be reproduced without expressed written consent from 2minutemedicine.com. Disclaimer: We present factual information directly from peer reviewed medical journals. No post should be construed as medical advice and is not intended as such by the authors, editors, staff or by 2minutemedicine.com. PLEASE SEE A HEALTHCARE PROVIDER IN YOUR AREA IF YOU SEEK MEDICAL ADVICE OF ANY SORT.  

Tags: asthmaquality improvement
Previous Post

Contraceptive prior to first intercourse linked with improved reproductive outcomes

Next Post

2 Minute Medicine Rewind June 9 – June 15, 2014

RelatedReports

Combination salmeterol-fluticasone therapy noninferior to fluticasone monotherapy for asthma events: The VESTRI trial
Artificial Intelligence

Artificial intelligence decision support software improved spirometry diagnosis performance in primary care

May 12, 2026
Evidence-based interventions for pediatric asthma successfully adapted for community health centers
Chronic Disease

Dupilumab use is associated with lower all-cause mortality but increased risk of lymphoma in asthma patients

January 13, 2026
Microbe-rich environment associated with lower rates of asthma
Chronic Disease

Dupilumab treatment is associated with improved mortality but increased risk of lymphoma in asthma patients

January 13, 2026
Postextubation administration of high-flow oxygen leads to reduced reintubation and respiratory failure
Weekly Rewinds

2 Minute Medicine Rewind September 29, 2025

September 29, 2025
Next Post
Primary care and specialists have comparable outcomes in treating Sleep Apnea

2 Minute Medicine Rewind June 9 – June 15, 2014

Home-based depression intervention effective for older African-Americans

Adverse childhood experiences identified by low-income, urban young adults

Caffeine affects teen boys, girls differently

Caffeine affects teen boys, girls differently

EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

5-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 5-day free trial

Then $4.99/month. Manage renewal in your account.

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Deep-learning model achieved high diagnostic performance for diabetic macular edema detection using optical coherence tomography (OCT) scans
  • FDA-cleared AI devices rarely have patient outcome data
  • Apixaban (Eliquis) is associated with reduced rates of ischemic stroke and bleeding in patients with atrial fibrillation and advanced chronic kidney disease compared with warfarin (Coumadin)
License Content
Terms of Use | Disclaimer
Cookie Policy
Cleantalk Pixel
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

5-day free trial · cancel anytime

Start 5-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free · only $4.16/month

Start 5-day free trial

Then $49.90/year. Manage renewal in your account.

Membership benefits

  • ✓100+ physician-written reports
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters

Already a member? Sign in

  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.